PGRN deficiency has been demonstrated to exacerbate pathological phenotypes, including Aβ plaque burden, neuroinflammatory markers, and memory impairment in AD mouse models in some studies (Minami et al, 2014; Van Kampen & Kay, 2017). Here, GRN is linked to Alzheimer disease.